Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
==========================================================================================================================================================================

* Karin Hägerbrand
* Laura Varas
* Adnan Deronic
* Barnabas Nyesiga
* Anette Sundstedt
* Lill Ljung
* Christina Sakellariou
* Doreen Werchau
* Mia Thagesson
* David Gomez Jimenez
* Lennart Greiff
* Mona Celander
* Kristine Smedenfors
* Anna Rosén
* Deniz Bölükbas
* Fredrika Carlsson
* Mattias Levin
* Anna Säll
* Laura von Schantz
* Malin Lindstedt
* Peter Ellmark